Expansion & Growth Qbtech has recently expanded its US footprint with new Houston offices and ongoing hiring, indicating growth potential in the American market. This creates opportunities to engage clinics, hospitals, and mental health networks in Texas and neighboring states that may benefit from scalable ADHD testing solutions.

Nonprofit Access The QbAccess program offering reduced-rate FDA-cleared ADHD testing to nonprofit healthcare organizations presents a compelling entry point for collaborations with clinics serving underfunded populations and large hospital systems with social impact goals.

Clinical Validation With FDA and MDR clearance and a long track record of objective ADHD data across ages 6-60, emphasize reliability and outcomes to drive partnerships with pediatric and adult neurology, psychiatry, and primary care networks seeking standardized diagnostic workflows.

Remote Workflow Solutions enable in-clinic or remote assessments, which aligns with growing telehealth adoption. Target telemedicine platforms, integrated care models, and multisite practices looking to streamline ADHD assessment and monitoring at scale.

Strategic Partnerships Past awards and collaborations with NHS/AHSN networks highlight a propensity for partner-led innovation. Propose co-development pilots, research collaborations, and education programs with health systems and academic institutions to expand adoption.